The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II trial of metronomic capecitabine and cyclophosphamide with lapatinib and trastuzumab in patients with HER2-positive metastatic breast cancer.
 
Irene Kang
Honoraria - Puma Biotechnology
Speakers' Bureau - Pfizer
Travel, Accommodations, Expenses - Peachtree Bioresearch Solutions
 
Darcy V. Spicer
No Relationships to Disclose
 
Janice M. Lu
No Relationships to Disclose
 
Susan G. Groshen
No Relationships to Disclose
 
Denice Tsao-Wei
No Relationships to Disclose
 
Agustin A. Garcia
Honoraria - Pfizer
Consulting or Advisory Role - Amgen; Novartis
Research Funding - Advenchen Laboratories (Inst); Boston Biomedical (Inst); Celldex (Inst); Merck (Inst); Seagen (Inst)